These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19568783)

  • 61. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathway.
    Lee HR; Toth Z; Shin YC; Lee JS; Chang H; Gu W; Oh TK; Kim MH; Jung JU
    J Virol; 2009 Jul; 83(13):6739-47. PubMed ID: 19369353
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of a p53-based portable degron based on the MDM2-p53 binding region.
    Melvin AT; Dumberger LD; Woss GS; Waters ML; Allbritton NL
    Analyst; 2016 Jan; 141(2):570-8. PubMed ID: 26456660
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Regulation of p53 and MDM2 activity by MTBP.
    Brady M; Vlatkovic N; Boyd MT
    Mol Cell Biol; 2005 Jan; 25(2):545-53. PubMed ID: 15632057
    [TBL] [Abstract][Full Text] [Related]  

  • 64. p53 promotes its own polyubiquitination by enhancing the HDM2 and HDMX interaction.
    Medina-Medina I; Martínez-Sánchez M; Hernández-Monge J; Fahraeus R; Muller P; Olivares-Illana V
    Protein Sci; 2018 May; 27(5):976-986. PubMed ID: 29524278
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The multiple levels of regulation by p53 ubiquitination.
    Lee JT; Gu W
    Cell Death Differ; 2010 Jan; 17(1):86-92. PubMed ID: 19543236
    [TBL] [Abstract][Full Text] [Related]  

  • 66. RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage.
    Fu X; Yucer N; Liu S; Li M; Yi P; Mu JJ; Yang T; Chu J; Jung SY; O'Malley BW; Gu W; Qin J; Wang Y
    Proc Natl Acad Sci U S A; 2010 Mar; 107(10):4579-84. PubMed ID: 20173098
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex.
    Weber JD; Kuo ML; Bothner B; DiGiammarino EL; Kriwacki RW; Roussel MF; Sherr CJ
    Mol Cell Biol; 2000 Apr; 20(7):2517-28. PubMed ID: 10713175
    [TBL] [Abstract][Full Text] [Related]  

  • 68. P53 mRNA controls p53 activity by managing Mdm2 functions.
    Candeias MM; Malbert-Colas L; Powell DJ; Daskalogianni C; Maslon MM; Naski N; Bourougaa K; Calvo F; Fåhraeus R
    Nat Cell Biol; 2008 Sep; 10(9):1098-105. PubMed ID: 19160491
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase.
    Okamoto K; Taya Y; Nakagama H
    FEBS Lett; 2009 Sep; 583(17):2710-4. PubMed ID: 19619542
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Why is F19Ap53 unable to bind MDM2? Simulations suggest crack propagation modulates binding.
    Dastidar SG; Lane DP; Verma CS
    Cell Cycle; 2012 Jun; 11(12):2239-47. PubMed ID: 22617389
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Dual Roles of MAGE-C2 in p53 Ubiquitination and Cell Proliferation Through E3 Ligases MDM2 and TRIM28.
    Liu Y; Cao B; Hu L; Ye J; Tian W; He X
    Front Cell Dev Biol; 2022; 10():922675. PubMed ID: 35927984
    [TBL] [Abstract][Full Text] [Related]  

  • 72. TRIAD1 is negatively regulated by the MDM2 E3 ligase.
    Bae S; Jung JH; An IS; Kim OY; Lee MJ; Lee JH; Park IC; Lee SJ; An S
    Oncol Rep; 2012 Nov; 28(5):1924-8. PubMed ID: 22940738
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase.
    Honda R; Yasuda H
    Oncogene; 2000 Mar; 19(11):1473-6. PubMed ID: 10723139
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mechanism of p53 stabilization by ATM after DNA damage.
    Cheng Q; Chen J
    Cell Cycle; 2010 Feb; 9(3):472-8. PubMed ID: 20081365
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity.
    Poyurovsky MV; Priest C; Kentsis A; Borden KL; Pan ZQ; Pavletich N; Prives C
    EMBO J; 2007 Jan; 26(1):90-101. PubMed ID: 17170710
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
    Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
    Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tripartite motif-containing protein 26 promotes colorectal cancer growth by inactivating p53.
    Lu H; Tan Z; Ko H; Naji P; Zhu R; Wang J; Huang S; Zhang YW; Zeng S
    Res Sq; 2024 Jan; ():. PubMed ID: 38260302
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival.
    Liu T; Zhang H; Xiong J; Yi S; Gu L; Zhou M
    Mol Cancer; 2015 Mar; 14():65. PubMed ID: 25888903
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Concepts in MDM2 Signaling: Allosteric Regulation and Feedback Loops.
    Ponnuswamy A; Hupp T; Fåhraeus R
    Genes Cancer; 2012 Mar; 3(3-4):291-7. PubMed ID: 23150762
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mdm2 and tumorigenesis: evolving theories and unsolved mysteries.
    Senturk E; Manfredi JJ
    Genes Cancer; 2012 Mar; 3(3-4):192-8. PubMed ID: 23150752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.